2025
article
OpenAlex
Lukas Zanders, S F Glaser, Mariano Ruz Jurado, Moritz Brandt et autres
Abstract Background Heart Failure with preserved ejection fraction (HFpEF) is a complex condition driven by diverse aetiologies and pathogenic mechanisms. It is one of the leading causes of death in industrialised nations. Despite its growing prevalence, therapies that improve survival remain largely …
de
(code pays fourni par la source)
2025
article
OpenAlex
M Aluia, Q Luo, Marin Kuntić, S Finger et autres
Abstract Background Arterial hypertension is a systemic cardiovascular disorder associated with detrimental effects orchestrated by Angiotensin II (AngII) in the renin-angiotensin-aldosterone system (RAAS). AngII causes vascular dysfunction, inflammation, and tissue damage. Increased expression of heme oxygenase-1 (HO-1) may confer antioxidant and anti-inflammatory …
de
(code pays fourni par la source)
2024
article
OpenAlex
Venkata Garlapati, Qi Luo, Jens Posma, M Aluia et autres
Abstract Background Excess fibrotic remodeling leads to cardiac dysfunction in ischemic heart disease and is driven by MAP kinase-dependent transforming growth factor-ß1 (TGF-ß1) activation by coagulation signaling of myeloid cells. How coagulation-inflammatory circuits can be specifically targeted to achieve beneficial macrophage reprogramming …
de, us, hr
(code pays fourni par la source)
2024
article
OpenAlex
Ornela Velollari, Maximilian Olschweski, Karl‐Patrik Kresoja, Jutta Herzog et autres
Abstract Background Heart failure (HF) is one of the leading causes of hospitalization in the elderly. Coronary microvascular dysfunction (CMD), among other risk factors, is linked to the pathogenesis and clinical manifestations of HF. Purpose This abstract aims to summarize key findings …
de
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Armin Scheffler, P Wenzel, Merle Bendig, Astrid Gendolla et autres
BACKGROUND: Eptinezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP mAb) and is used for migraine prophylaxis. Efficacy data are mainly from clinical trials, real-world data are hardly available yet. Reimbursement policy in Germany leads to eptinezumab mainly being used …
de
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Venkata Garlapati, Michael Molitor, Thomas Michna, Sonja Finger et autres
Accès ouvert
2022
article
OpenAlex
Maximilian Peter Brandt, Sana’a Khraisat, Hendrik Doerschmann, Sanela Kalinovic et autres
Abstract Background Heart failure (HF) coincides with cardiomyocyte telomere shortening. Arterial hypertension is the most prominent risk factor for HF. Both HF and arterial hypertension are associated with dysregulation of the neurohormonal axis and increased ROS. However, how neurohormonal activation is linked …
de
(code pays fourni par la source)
2022
article
OpenAlex
M Aluia, Marin Kuntić, K. Jurk, Andreas Daiber et autres
Abstract Background Arterial hypertension is one of the most important modifiable risk factors for all-cause morbidity and mortality worldwide. Angiotensin II (Ang II) plays a pathogenic role in the development of hypertension, vascular dysfunction, inflammation and tissue damage. In the context of …
de
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Maximilian Peter Brandt, H Doerschmann, Sanela Kalinovic, Andreas Daiber et autres
Abstract The mechanisms and clinical significance of telomere shortening in heart failure remain elusive. Mammalian cardiomyocyte (CM) regeneration is limited and CM cell division cannot account for telomere shortening. Whether telomere shortening in turn affects cardiac recovery remains unexplored. We induced heart …
de
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
E. André, Elisa Yaniz‐Galende, Charles Hamilton, Gregory J. Dusting et autres
Emerging evidence supports a mandatory metabolic shift from glycolysis to oxidative phosphorylation during stem cells differentiation. In this study, we investigate cardiac progenitor cells (CPC) metabolic adaptations to a hypoxic environment and the bioenergetic transition underlying cardiomyocyte differentiation process. We intend to …
1981
article
OpenAlex
B. E. Wenzel, P Wenzel, Klaus Wenzel, Ringo Wenzel et autres
de
(code pays fourni par la source)